Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor’s kidneys’ outcome in a European cohort
The Kidney Donor Profile Index (KDPI) was introduced in the United States in 2014 to guide the decision making of clinicians with respect to accepting or declining a donated kidney. To evaluate whether the KDPI can be applied to a European cohort, we retrospectively assessed 580 adult patients who u...
| Verfasser: | |
|---|---|
| FB/Einrichtung: | FB 05: Medizinische Fakultät |
| Dokumenttypen: | Artikel |
| Medientypen: | Text |
| Erscheinungsdatum: | 2019 |
| Publikation in MIAMI: | 03.07.2020 |
| Datum der letzten Änderung: | 03.07.2020 |
| Angaben zur Ausgabe: | [Electronic ed.] |
| Quelle: | Scientific Reports 9 (2019) 11234, 1-11 |
| Schlagwörter: | Outcomes research; Renal replacement therapy |
| Fachgebiet (DDC): | 610: Medizin und Gesundheit |
| Lizenz: | CC BY 4.0 |
| Sprache: | English |
| Förderung: | Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster). |
| Format: | PDF-Dokument |
| URN: | urn:nbn:de:hbz:6-30189601271 |
| Weitere Identifikatoren: | DOI: 10.1038/s41598-019-47772-7 |
| Permalink: | https://nbn-resolving.de/urn:nbn:de:hbz:6-30189601271 |
| Verwandte Dokumente: |
|
| Onlinezugriff: | artikel_reuter_2019.pdf
zusatzmaterial_reuter_2019.pdf |
| Daten herunterladen: | ZIP-Datei |
The Kidney Donor Profile Index (KDPI) was introduced in the United States in 2014 to guide the decision making of clinicians with respect to accepting or declining a donated kidney. To evaluate whether the KDPI can be applied to a European cohort, we retrospectively assessed 580 adult patients who underwent renal transplantation (brain-dead donors) between January 2007 and December 2014 at our center and compared their KDPIs with their short- and long-term outcomes. This led to the observation of two associations: one between the KDPI and the estimated glomerular filtration rate at one year (1-y-eGFR) and the other between the KDPI and the death-censored allograft survival rate (both p